Several studies have demonstrated that RAB31 is correlated with prognosis in patients with breast, ovarian, liver cancer, and glioblastoma (Grismayer et al., 2012; Kotzsch et al., 2011; Serao et al., 2011; Sui et al., 2015). This evidence concerns the gene RAB31 and liver cancer.